164 related articles for article (PubMed ID: 902672)
1. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
Fagard R; Amery A; Lijnen P; Reybrouck T
Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.
Leonetti G; Terzoli L; Sala C; Bianchini C; Sernesi L; Zanchetti A
Clin Sci Mol Med Suppl; 1978 Dec; 4():307s-309s. PubMed ID: 282074
[TBL] [Abstract][Full Text] [Related]
5. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Schroeder ET; Anderson GH; Goldman SH; Streeten DH
Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
[TBL] [Abstract][Full Text] [Related]
6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
Van Hoogdalem P; Donker AJ; Leenen FH
Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
[TBL] [Abstract][Full Text] [Related]
8. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
Anderson GH; Streeten DH; Dalakos TG
Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
[TBL] [Abstract][Full Text] [Related]
10. Pressor response to saralasin (1-sar-8-ala-angiotensin II) bolus injection in hypertensive patients.
Waks UA; Maxwell MH; Marks L; Zawada ET; Kaufman JJ
Circulation; 1978 Jun; 57(6):1165-70. PubMed ID: 639240
[TBL] [Abstract][Full Text] [Related]
11. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
[TBL] [Abstract][Full Text] [Related]
13. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
Macdonald GJ; Boyd GW; Peart WS
Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Brunner HR; Gavras H; Ribeiro AB; Posternak L
Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion.
Hata T; Ogihara T; Mikami H; Nakamaru M; Maruyama A; Mandai T; Kumahara Y
Life Sci; 1978 Jun; 22(21):1955-62. PubMed ID: 672437
[No Abstract] [Full Text] [Related]
18. Hypotensive effect of [Sar1,Thr8]angiotensin II in spontaneously hypertensive sodium-depleted rats.
Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA
Am J Physiol; 1978 Apr; 234(4):H447-53. PubMed ID: 645884
[TBL] [Abstract][Full Text] [Related]
19. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
20. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
